Galectin Therapeutics Cash from Financing (TTM) Analysis

Galectin Therapeutics Inc (GALT)

3.22 -0.02 (-0.62%) USD | NASDAQ | May 09, 16:00

3.18 -0.04 (-1.24%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2002. Upgrade now.

Date	Value
December 31, 2023	40.03M
September 30, 2023	40.03M
June 30, 2023	30.00M
March 31, 2023	20.00M
December 31, 2022	10.00M
September 30, 2022	9.999M
June 30, 2022	20.00M
March 31, 2022	36.81M
December 31, 2021	36.81M
September 30, 2021	26.82M
June 30, 2021	16.82M
March 31, 2021	0.044M
December 31, 2020	0.263M
September 30, 2020	1.165M
June 30, 2020	0.934M
March 31, 2020	48.29M
December 31, 2019	50.08M
September 30, 2019	49.30M
June 30, 2019	50.74M
March 31, 2019	12.93M
December 31, 2018	15.38M
September 30, 2018	15.25M
June 30, 2018	14.99M
March 31, 2018	5.889M
December 31, 2017	3.583M

Date	Value
September 30, 2017	7.752M
June 30, 2017	8.298M
March 31, 2017	8.07M
December 31, 2016	5.925M
September 30, 2016	10.88M
June 30, 2016	9.426M
March 31, 2016	9.169M
December 31, 2015	13.70M
September 30, 2015	5.613M
June 30, 2015	5.632M
March 31, 2015	5.873M
December 31, 2014	31.46M
September 30, 2014	32.84M
June 30, 2014	38.88M
March 31, 2014	38.66M
December 31, 2013	8.609M
September 30, 2013	6.189M
June 30, 2013	0.09M
March 31, 2013	0.077M
December 31, 2012	10.40M
September 30, 2012	10.40M
June 30, 2012	11.62M
March 31, 2012	14.18M
December 31, 2011	6.197M
September 30, 2011	9.857M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.044M

Minimum

Mar 2021

50.74M

Maximum

Jun 2019

25.69M

Average

26.82M

Median

Sep 2021

Cash from Financing (TTM) Benchmarks